Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

15

Jul 2019

Gilead and Galapagos Enter Into Transformative Research and Development Collaboration

Gilead Sciences Inc and Galapagos NV announced that they have entered into a year global research and development collaboration Through this agreement Gilead will gain access to an innovative portfolio of compounds including six molecules currently

15

Jul 2019

Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for People Who Have Difficulty Swallowing

Sun Pharmaceutical Industries Ltd today announced the US launch of Ezallor Sprinkle rosuvastatin capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing a problem that is estimated to affect approximately of longterm care residents

12

Jul 2019

Forty Seven, Inc. and Ono Pharmaceutical Co., Ltd. Sign Regional License Agreement to Develop, Manufacture and Commercialize 5F9

Forty Seven Inc a clinicalstage immunooncology company focused on developing therapies to activate macrophages in the fight against cancer and Ono Pharmaceutical Co Ltd today announced an exclusive license agreement for the development manufacture and commercialization of F Forty Sevens monoclonal a...

12

Jul 2019

Ivy Brain Tumor Center and Karyopharm Therapeutics Collaborate to Develop Tissue-Based Clinical Trial for Brain Cancer

The Ivy Brain Tumor Center at the Barrow Neurological Institute has announced a partnership with Karyopharm Therapeutics to accelerate the treatment of brain cancer The Ivy Brain Tumor Center will employ Karyopharms firstinclass oral Selective Inhibitor of Nuclear Export SINE compound selinexor in c...

11

Jul 2019

Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio

Altimmune Inc a clinicalstage biopharmaceutical company today announced that it has entered into an agreement to acquire Spitfire Pharma Inc Spitfire including its product candidate SP to be renamed ALT a potent GLPGlucagon receptor coagonist for the treatment of nonalcoholic steatohepatitis NASH Th...

press releasesRead more...

15

Jul 2019

New State Of The Art Cleanroom Completed By WHP For ADC Bio

Production of new anticancer drugs at ADC Bios North Wales manufacturing plant has been boosted following completion of a new cleanroom facility designed and built by WHP This forms a key part of ADC Bios construction of a new bioconjugation facility at its site in Deeside

15

Jul 2019

Ascentage Pharma announces first patient dosed in Phase I clinical trial of APG-2575 in China as the first China-made Bcl-2 Inhibitor

Ascentage Pharma a globallyfocused clinicalstage biotechnology company engaged in developing novel therapies for cancers hepatitis B virus and agerelated diseases today announced that the company recently dosed the first patient successfully in a Phase I clinical trial of APG

15

Jul 2019

EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies

EIP Pharma Inc a CNSfocused therapeutics company today announced the initiation of a new Phase proofofconcept study evaluating neflamapimod as a treatment for the cognitive dysfunction associated with dementia with Lewy bodies DLB

12

Jul 2019

Sensorion Receives FDA IND Approval for Arazasetron (SENS-401)

Sensorion a pioneering clinicalstage biopharmaceutical company which specializes in the development of novel therapies to restore treat and prevent inner ear diseases such as hearing loss tinnitus and vertigo announces today that it has received the Investigational New Drug IND clearance from the U...

12

Jul 2019

H2-Pharma and CHEPLAPHARM Announce Launch of ETOPOPHOS® Injection

HPharma LLC a privately held pharmaceutical company announced today that it has entered into an agreement with CHEPLAPHARM Arzneimittel GmbH to be the exclusive US distributor of ETOPOPHOS etoposide phosphate for injection

EventsRead more...

15 - 16

Jul 2019

Physiotherapy, Sports medicine and Doping Studies

conference series
Mantra Parramatta

19 - 20

Jul 2019

8th International Conference on Clinical Trials

Conference Series LLC Ltd
Atlanta

19 - 20

Jul 2019

7th World Heart Congress

Heart Conferences
Vienna

24 - 25

Jul 2019

Advertisements

Rousselot - X-PURE®

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

EDITORIAL SECTION